Healthtech Startups
16,988 companies tagged Healthtech, with their investors and founders.
Yuzu rebuilds health insurance from the ground up, replacing fragmented point solutions with an integrated system designed to realign incentives among providers, patients, and payers.
2 investors
Zdorovie.ru develops digital health platforms and software solutions for the healthcare sector, offering patients online health diaries and analytics tools while providing doctors with diagnostic and treatment monitoring capabilities.
2 investors
Zenopsys is an AI-native documentation workspace for authoring, reviewing, and submitting drug development documents such as clinical protocols, CSRs, and eCTD dossiers (IND, ANDA, NDA, MAA). It serves pharma companies, generics manufacturers, biotech, CRDMOs, and regulatory consultants, with support for major regulatory agencies and markets.
2 investors
Zentalis is a biopharmaceutical company developing azenosertib and other pipeline assets, seeking strategic partnerships to advance drug development and expand market reach globally.
2 investors
Zenyum manufactures and sells direct-to-consumer oral care products including invisible braces, electric toothbrushes, teeth whitening kits, water flossers, and toothpaste.
2 investors
Zeto develops improved electroencephalography technology for diagnosing epilepsy and other neurological conditions. The company serves physicians and medical institutions seeking advanced EEG diagnostic tools.
2 investors
Zorro provides a platform that uses data science to help employers manage health benefits more flexibly, allowing employees to select coverage that matches their individual needs rather than rigid group plans.
2 investors
Zuri Health provides on-demand, affordable healthcare accessible via mobile devices, including virtual care, screening tools, and health services for patients across Africa. The company focuses on expanding healthcare access in underserved Sub-Saharan African communities.
2 investors
ZYMEDI is a drug discovery company that partners through R&D joint ventures, strategic investments, and in-licensing arrangements. It works with collaborators across the pharmaceutical and biotechnology sector.
2 investors
Zymego provides appointment management software for healthcare clinics that enables patients to self-book, reschedule, and cancel appointments autonomously, reducing no-shows and wait times. The platform is designed to eliminate wasted appointment slots and free up administrative staff time in healthcare settings.
2 investors
Dr. Diary is an employee wellness platform that integrates health monitoring devices (smart scales, blood pressure monitors) and app-based data collection to provide enterprises with comprehensive health management programs including glucose monitoring, blood pressure tracking, weight management, and prenatal care.
2 investors
Ronfic combines AI exercise/movement data with robotic hardware to build integrated training systems, targeting sports, medical, fitness, and senior-care users. Founded in South Korea, it develops training environments based on users' physical characteristics and real movement patterns.
2 investors
APITbio develops antibody-based therapeutics using a proprietary fully human antibody library, with platforms for antibody discovery, engineering, optimization, production, and bispecific antibody creation. Its pipeline includes monoclonal antibodies, bispecific antibodies, and a CAR-T program under joint research.
2 investors
L&K Biomed develops spinal medical devices and related surgical products. The company focuses on research and development of orthopedic and spine healthcare technology.
2 investors
Ubix Therapeutics (주식회사 유빅스테라퓨틱스) is a South Korean company whose services include a health-management offering that processes health data such as blood oxygen saturation, blood glucose, blood pressure, heart rate, height, and weight. The page reviewed is a privacy policy and gives limited detail about the company's core business.
2 investors
PNTbiz operates IndoorPlus+, a real-time location and asset tracking platform that uses RTLS, location-based services, and smart sensing technologies for indoor monitoring and navigation. The platform serves hospitals, enterprises, and industrial facilities for applications including worker safety, asset management, access control, and environmental monitoring.
2 investors
Airato is a Japanese medical device startup developing AI-powered software for radiation therapy planning and delivery. The company aims to improve cancer treatment outcomes and quality of life for patients through advanced radiation oncology technology.
2 investors
IMMUNOSENS manufactures in vitro diagnostic pharmaceuticals and third-class medical devices for clinical diagnostic purposes. The company holds regulatory approvals from Japanese authorities for these medical products.
2 investors
AI Silk manufactures and sells lead skins (electrodes) and related electrode application products. The company serves medical and industrial sectors requiring specialized electrode technology.
2 investors
Orizuru Therapeutics develops cellular therapy products and regenerative medicine treatments utilizing iPS cell-related technology. The company supports drug discovery research and establishes regenerative medicine research infrastructure for the Japanese healthcare and biotechnology sectors.
2 investors
A Japanese media and digital marketing company that operates video and SNS platforms focused on the elderly care sector, providing video production services for care facilities and a talent platform to support care workers.
2 investors
Cuorips develops regenerative medicine products based on human iPS cell technology, including its heart muscle cell sheet "Heart®" (Rehart) for treating severe heart failure caused by ischemic cardiomyopathy, along with catheter-based therapies and compound drugs (YS series). The Japan-based company, spun out of Osaka University research, also builds cell mass-manufacturing infrastructure (VMaCS) and is listed on the Tokyo Stock Exchange Growth market.
2 investors
Kringle Pharma develops and manufactures HGF protein-based pharmaceuticals for treating conditions including spinal cord injury, ALS, and vocal cord scarring. The company is a spin-out of Osaka University and Keio University focused on drug development in the biotech sector.
2 investors
Solasia is a pharmaceutical company that in-licenses promising drug candidates from overseas and domestic pharma and biotech companies and develops them through clinical trials for the Japanese and Asian markets. Founded in 2006, it focuses on supplying cancer-related medicines to patients across Japan and other Asian countries.
2 investors